Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Page 1
[Kidney transplantation for end-stage renal disease after third allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia].
Nishijima A, Shingai N, Ohta A, Suda K, Omoto K, Ishida S, Yoshioka K, Kurosawa S, Hino Y, Senoo Y, Igarashi A, Oshikawa G, Hamamura A, Toya T, Shimizu H, Najima Y, Kobayashi T, Haraguchi K, Okuyama Y, Ohashi K, Doki N. Nishijima A, et al. Among authors: kurosawa s. Rinsho Ketsueki. 2024;65(1):7-12. doi: 10.11406/rinketsu.65.7. Rinsho Ketsueki. 2024. PMID: 38311391 Japanese.
Immunosuppressive therapy with methylprednisolone, tacrolimus, and mycophenolate mofetil was started for kidney transplantation, but the dose of immunosuppressive agents was reduced successfully without rejection soon after kidney transplantation. The patient has maintained long- …
Immunosuppressive therapy with methylprednisolone, tacrolimus, and mycophenolate mofetil was started for kidney transplantation, but the dos …
Incidence and predictors of recurrent sick leave in survivors who returned to work after allogeneic hematopoietic cell transplantation.
Kurosawa S, Yamaguchi T, Mori A, Matsuura T, Masuko M, Murata M, Tashiro H, Kako S, Satake A, Hagihara M, Ota S, Saito T, Kagawa K, Matsuo Y, Itonaga H, Uoshima N, Yamaguchi H, Naito K, Takahashi M, Fukuda T. Kurosawa S, et al. J Cancer Surviv. 2023 Jun;17(3):781-794. doi: 10.1007/s11764-022-01250-8. Epub 2022 Sep 1. J Cancer Surviv. 2023. PMID: 36048313
Multi-professional teams that provide continuous support and effective communication with the workplace are necessary to improve long-term outcomes after allo-HCT. IMPLICATIONS FOR CANCER SURVIVORS: In order to continue working after the initial return to work, it is impor …
Multi-professional teams that provide continuous support and effective communication with the workplace are necessary to improve long-ter …
Feasibility and usefulness of recommended screenings at long-term follow-up clinics for hematopoietic cell transplant survivors.
Kurosawa S, Yamaguchi T, Mori A, Tsukagoshi M, Okuda I, Ikeda M, Ueno T, Saito Y, Aihara Y, Matsuba Y, Fuji S, Yamashita T, Ogawa C, Ito A, Tanaka T, Inamoto Y, Kim SW, Fukuda T. Kurosawa S, et al. Support Care Cancer. 2022 Mar;30(3):2767-2776. doi: 10.1007/s00520-021-06698-5. Epub 2021 Nov 27. Support Care Cancer. 2022. PMID: 34837539
PURPOSE: Advances in allogeneic hematopoietic cell transplantation (allo-HCT) have resulted in a growing number of transplant survivors; however, long-term survivors are at risk of developing late complications, and published guidelines recommend screening of this populati …
PURPOSE: Advances in allogeneic hematopoietic cell transplantation (allo-HCT) have resulted in a growing number of transplant survivors; how …
Prognostic Impact of Pretransplantation Quality of Life and Its Post-Transplantation Longitudinal Change after Allogeneic Hematopoietic Cell Transplantation: A Prospective Study That Administered the Short-Form Health Survey (SF-12) and EuroQol 5.
Kurosawa S, Yamaguchi T, Mori A, Tsukagoshi M, Okuda I, Ikeda M, Fuji S, Yamashita T, Ogawa C, Ito A, Tanaka T, Inamoto Y, Kim SW, Fukuda T. Kurosawa S, et al. Transplant Cell Ther. 2021 Nov;27(11):935.e1-935.e9. doi: 10.1016/j.jtct.2021.07.026. Epub 2021 Aug 8. Transplant Cell Ther. 2021. PMID: 34371214 Free article.
In allogeneic hematopoietic cell transplantation (allo-HCT), investigator-based clinical variables have been used for pretransplantation prognostic prediction, risk adjustment, and post-transplantation long-term screenings. Although several studies have investigated the pr …
In allogeneic hematopoietic cell transplantation (allo-HCT), investigator-based clinical variables have been used for pretransplantation pro …
[Survivorship and long-term follow-up after allogeneic hematopoietic stem cell transplantation].
Kurosawa S. Kurosawa S. Rinsho Ketsueki. 2021;62(6):610-618. doi: 10.11406/rinketsu.62.610. Rinsho Ketsueki. 2021. PMID: 34219088 Japanese.
Allogeneic hematopoietic cell transplantation (allo-HCT) is a curative treatment strategy; however, long-term survivors of allo-HCT are at risk of experiencing late adverse effects, including chronic graft-versus-host disease, immunocompromised status, endocrine diseases, …
Allogeneic hematopoietic cell transplantation (allo-HCT) is a curative treatment strategy; however, long-term survivors of allo-HCT a …
Identifying typologies of diurnal patterns in desk-based workers' sedentary time.
Kurosawa S, Shibata A, Ishii K, Koohsari MJ, Oka K. Kurosawa S, et al. PLoS One. 2021 Apr 9;16(4):e0248304. doi: 10.1371/journal.pone.0248304. eCollection 2021. PLoS One. 2021. PMID: 33836010 Free PMC article.
Participants in the off-morning and off-afternoon break clusters had nearly the same sedentary patterns but took short-term breaks during non-workday mornings or afternoons. The evening sedentary cluster had a completely different pattern, with a longer sedentary time duri …
Participants in the off-morning and off-afternoon break clusters had nearly the same sedentary patterns but took short-term breaks du …
Effects of performing a lateral-reaching exercise while seated on a tilted surface for severe post-stroke pusher behavior: A case series.
Fukata K, Amimoto K, Inoue M, Shida K, Kurosawa S, Inoue M, Fujino Y, Makita S, Takahashi H. Fukata K, et al. Among authors: kurosawa s. Top Stroke Rehabil. 2021 Dec;28(8):606-613. doi: 10.1080/10749357.2020.1861718. Epub 2020 Dec 20. Top Stroke Rehabil. 2021. PMID: 33345722
Future studies to examine the adaptability of this task and long-term effects are needed....
Future studies to examine the adaptability of this task and long-term effects are needed....
Current Status and Needs of Long-Term Follow-Up Clinics for Hematopoietic Cell Transplantation Survivors: Results of a Nationwide Survey in Japan.
Kurosawa S, Mori A, Tsukagoshi M, Onishi Y, Ohwada C, Mori T, Goto H, Asano-Mori Y, Nawa Y, Hino M, Fukuchi T, Mori Y, Yamahana R, Inamoto Y, Fukuda T. Kurosawa S, et al. Biol Blood Marrow Transplant. 2020 May;26(5):949-955. doi: 10.1016/j.bbmt.2020.01.008. Epub 2020 Jan 18. Biol Blood Marrow Transplant. 2020. PMID: 31962164 Free article.
With increasing focus on the importance of long-term survivorship care after allogeneic hematopoietic cell transplantation (allo-HCT), more institutions have been establishing long-term follow-up (LTFU) clinics. ...We found that staffing and standard practices varie …
With increasing focus on the importance of long-term survivorship care after allogeneic hematopoietic cell transplantation (allo-HCT) …
The emergence of rare nocardiosis following allogeneic hematopoietic stem cell transplantation in the era of molecular taxonomy.
Kurosawa S, Sekiya N, Doki N, Yaguchi T, Kishida Y, Nagata A, Yamada Y, Konishi T, Kaito S, Yoshifuji K, Shirane S, Uchida T, Inamoto K, Toya T, Igarashi A, Najima Y, Muto H, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K. Kurosawa S, et al. Int J Infect Dis. 2019 Dec;89:154-162. doi: 10.1016/j.ijid.2019.10.003. Epub 2019 Oct 9. Int J Infect Dis. 2019. PMID: 31605809 Free article. Review.
CONCLUSION: Newly identified Nocardia species have various antimicrobial susceptibility patterns. Long-term maintenance therapy could be challenging due to the adverse events of antimicrobials, especially in the allo-HSCT setting. ...
CONCLUSION: Newly identified Nocardia species have various antimicrobial susceptibility patterns. Long-term maintenance therapy could …
SAPPHIRE: a randomised phase II study of planned discontinuation or continuous treatment of oxaliplatin after six cycles of modified FOLFOX6 plus panitumumab in patients with colorectal cancer.
Munemoto Y, Nakamura M, Takahashi M, Kotaka M, Kuroda H, Kato T, Minagawa N, Noura S, Fukunaga M, Kuramochi H, Touyama T, Takahashi T, Miwa K, Satake H, Kurosawa S, Miura T, Mishima H, Sakamoto J, Oba K, Nagata N. Munemoto Y, et al. Among authors: kurosawa s. Eur J Cancer. 2019 Sep;119:158-167. doi: 10.1016/j.ejca.2019.07.006. Epub 2019 Aug 21. Eur J Cancer. 2019. PMID: 31445198 Free article. Clinical Trial.
BACKGROUND: Fluorouracil (5-FU), leucovorin (LV) and oxaliplatin (FOLFOX) plus panitumumab therapy is a commonly used first-line chemotherapy for metastatic colorectal cancer (mCRC). However, the long-term administration of oxaliplatin is associated with peripheral neuropa …
BACKGROUND: Fluorouracil (5-FU), leucovorin (LV) and oxaliplatin (FOLFOX) plus panitumumab therapy is a commonly used first-line chemotherap …
33 results